Sorbitan ester niosomes for topical delivery of rofecoxib
- PMID: 21702223
Sorbitan ester niosomes for topical delivery of rofecoxib
Abstract
The aim of the present investigation is to encapsulate rofecoxib in niosomes and incorporate the prepared niosomes into dermal gel base for sustained therapeutic action. Niosomes were prepared by lipid film hydration technique and were analyzed for size, entrapment efficiency and drug retention capacity. Niosomal vesicles were then incorporated into blank carbopol gel to form niosomal gel. The in vitro permeation study across pig skin was performed using Keshary-Chien glass diffusion cell. The size and entrapment efficiency of the niosomal vesicles increased with gradual increase in HLB value of nonionic surfactants used. Maximum drug entrapment was observed with Span 20 with HLB value of 8.6 and drug leakage from vesicles was less at refrigerated condition than at the room temperature. Higher proportion of cholesterol made the niosomal formulation more stable with high drug retention properties. The niosomal gel showed a prolong drug release behavior compared to plain drug gel. Differential scanning calorimetric study of drug loaded gel and pig skin after permeation study confirmed inertness of carbopol gel base toward rofecoxib and absence of drug metabolism in the skin during permeation study, respectively. The niosomal formulations were successfully prepared by lipid film hydration technique using cholesterol and Span as nonionic surfactant. Presence of cholesterol made niosomes more stable with high drug entrapment efficiency and retention properties. The lower flux value of niosomal gel as compared to plain drug gel across pig skin assured the prolong drug release behavior with sustained action.
Similar articles
-
Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.Int J Pharm. 2009 Jul 30;377(1-2):1-8. doi: 10.1016/j.ijpharm.2009.04.020. Epub 2009 Apr 24. Int J Pharm. 2009. PMID: 19394413
-
Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.Int J Pharm. 2005 Dec 8;306(1-2):71-82. doi: 10.1016/j.ijpharm.2005.09.023. Epub 2005 Nov 2. Int J Pharm. 2005. PMID: 16263229
-
Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis.J Liposome Res. 2010 Dec;20(4):341-50. doi: 10.3109/08982101003596125. Epub 2010 Feb 18. J Liposome Res. 2010. PMID: 20163329
-
Proniosomes as drug carriers.Pak J Pharm Sci. 2010 Jan;23(1):103-7. Pak J Pharm Sci. 2010. PMID: 20067875 Review.
-
Vesicular carriers for dermal drug delivery.Expert Opin Drug Deliv. 2009 Aug;6(8):813-25. doi: 10.1517/17425240903071029. Expert Opin Drug Deliv. 2009. PMID: 19569979 Review.
Cited by
-
Formulation of Nanospanlastics as a Promising Approach for Improving the Topical Delivery of a Natural Leukotriene Inhibitor (3-Acetyl-11-Keto-β-Boswellic Acid): Statistical Optimization, in vitro Characterization, and ex vivo Permeation Study.Drug Des Devel Ther. 2020 Sep 15;14:3697-3721. doi: 10.2147/DDDT.S265167. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32982176 Free PMC article.
-
Niosome Preparation Techniques and Structure-An Illustrated Review.Pharmaceutics. 2025 Jan 6;17(1):67. doi: 10.3390/pharmaceutics17010067. Pharmaceutics. 2025. PMID: 39861715 Free PMC article. Review.
-
Long-Lasting, Antinociceptive Effects of pH-Sensitive Niosomes Loaded with Ibuprofen in Acute and Chronic Models of Pain.Pharmaceutics. 2019 Feb 1;11(2):62. doi: 10.3390/pharmaceutics11020062. Pharmaceutics. 2019. PMID: 30717144 Free PMC article.
-
Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement.ScientificWorldJournal. 2014 Feb 2;2014:959741. doi: 10.1155/2014/959741. eCollection 2014. ScientificWorldJournal. 2014. PMID: 24672401 Free PMC article.
-
Formulation of Sodium Valproate Nanospanlastics as a Promising Approach for Drug Repurposing in the Treatment of Androgenic Alopecia.Pharmaceutics. 2020 Sep 11;12(9):866. doi: 10.3390/pharmaceutics12090866. Pharmaceutics. 2020. PMID: 32933001 Free PMC article.